EASD 2025
15 - 19 September 2025
Improved treatment satisfaction with once-weekly IcoSema vs daily basal-bolus therapy in adults with type 2 diabetes inadequately controlled on daily basal insulin (COMBINE 3)
Affiliations
View Details
Hide Details
Keywords
Get notified when materials for EASD 2025 and future congresses become available:
Get notified when materials for EASD 2025 and future congresses become available:
Success
We will notify you when new materials become available for EASD 2025 and future congresses.
We will keep you updated in your inbox:
Almost Done